(Q35632466)

English

Biological therapy for psoriasis: an overview of infliximab, etanercept, efalizumab and alefacept.

scientific article published on January 2004

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

review article

1 reference

stated in

Europe PubMed Central

title

Biological therapy for psoriasis: an overview of infliximab, etanercept, efalizumab and alefacept (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

author name string

William D Tutrone

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

Rita Saini

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

Jeffery M Weinberg

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

language of work or name

1 reference

1 January 2004

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

published in

IDrugs: the Investigational Drugs Journal

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

volume

7

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

page(s)

45-49

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 November 2019

Identifiers

PubMed ID

14730466

1 reference

stated in

Europe PubMed Central

PubMed ID

14730466

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14730466%20AND%20SRC:MED&resulttype=core&format=json

(Q35632466)

Biological therapy for psoriasis: an overview of infliximab, etanercept, efalizumab and alefacept.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)